{{Drugbox
| verifiedrevid = 447997208
| IUPAC_name = 5-Imino-3-(1-phenylpropan-2-yl)-5''H''-1,2,3-oxadiazol-3-ium-2-ide
| image = Feprosidnine_chemical_structure.png
| width = 200

<!--Clinical data-->
| tradename =  
| legal_status =  
| routes_of_administration =

<!--Pharmacokinetic data-->
| metabolism =  
| elimination_half-life =  
| excretion =

<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 3441-64-3
| ATC_prefix = none
| PubChem = 72088
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 65073
| ChEMBL = 2104320
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 1G4W8NR1PT

<!--Chemical data-->
| C=11 | H=13 | N=3 | O=1 
| molecular_weight = 203.24 g/mol
| smiles = n1oc([NH-])c[n+]1C(Cc2ccccc2)C
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C11H13N3O/c1-9(14-8-11(12)15-13-14)7-10-5-3-2-4-6-10/h2-6,8-9,12H,7H2,1H3
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = HFLCEELTJROKMJ-UHFFFAOYSA-N
}}

'''Feprosidnine''' ('''Sydnophen''') is a [[stimulant]] drug which was developed in the [[USSR]] in the 1970s.<ref>Veksler IG, Riabukha VN, Balitskiĭ KP, Al'tshuler RA, Mashkovskiĭ MD. Immunostimulating and antitumor action of psychotropic preparations of the sydnonimine series. (Russian) ''Farmakologiia i Toksikologiia''. 1980 May-Jun;43(3):349-52.</ref><ref>Koniaeva EI, Beketov AI. Effect of caffeine and sidnofen on the blood supply of the brain, kidneys and hindlimbs during antiorthostatism. (Russian) ''Farmakologiia i Toksikologiia'' 1987 May-Jun;50(3):39-42.</ref> It is structurally related to another Russian drug [[mesocarb]] but unlike Mesocarb, was withdrawn earlier from production. In comparison with Mesocarb it has own antidepressant activity, which makes it useful in treating depressions. Indications of Feprosidnine included apathic, asthenic depressions, fatique, apathic syndrome, narcolepsy and other similar conditions. Therapeutic range of doses: 10-50mg a day.
Sydnophen has multiple mechanisms of action, the relative importance of which has not been clearly established. Effects on the body include reversible monoamine oxidase inhibition, [[acetylcholine|cholinergic]],<ref>Samonina GE, Mandriko EV. Peripheral cholinolytic action--one of the effects of sidnofen. (Russian) ''Biulleten Eksperimental'noi Biologii i Meditsiny''. 1989 Apr;107(4):449-51.</ref> [[adrenaline|adrenergic]],<ref>Babskaia NE. Sidnofen-dependent pre- and postsynaptic activation of peripheral adrenergic transmission. (Russian) ''Eksperimental'naia i Klinicheskaia Farmakologiia''. 1992 Sep-Oct;55(5):21-5.</ref> [[opioid]]<ref>D'iakonova TL, Samonina GE. The naloxone-dependent effects of the psychostimulant sidnofen: a study on identified neurons of the snail. (Russian) ''Zhurnal Vysshei Nervnoi Deiatelnosti Imeni I P Pavlova''. 1994 Jul-Oct;44(4-5):786-95.</ref> and [[Endothelium-derived relaxing factor|nitric oxide donating]]<ref>Arzamastsev AP, Severina IS, Grigor'ev NB, Granik VG. Exogenous donors of nitric oxide and inhibitors of NO-synthase (chemical aspects). (Russian). ''Vestnik Rossiiskoi Akademii Meditsinskikh Nauk''. 2003;(12):88-95.</ref> actions, all of which may contribute to its pharmacological effects to some extent.

== Chemistry ==
Feprosidnine is a [[mesoionic]] [[sydnone imine]].

== References ==
{{Reflist}}


{{Stimulants}}
{{Monoamine releasing agents}}
{{Nitric oxide signaling modulators}}

[[Category:Stimulants]]
[[Category:Oxadiazoles]]
[[Category:Russian drugs]]
[[Category:Monoamine releasing agents]]
[[Category:Drugs in the Soviet Union]]